539PTUMOR HETEROGENEITY AND EFFICACY OF FIRST-LINE CETUXIMAB + FOLFIRI IN KRAS MUTANT METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS) OF THE CAPRI GOIM TRIAL.
Annals of oncology : official journal of the European Society for Medical Oncology（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要